Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice.

Stoddart A, Tennant TR, Fernald AA, Anastasi J, Brodsky FM, Le Beau MM.

Oncogene. 2012 Jan 26;31(4):494-506. doi: 10.1038/onc.2011.251. Epub 2011 Jun 27.

2.

The role of CALM-AF10 gene fusion in acute leukemia.

Caudell D, Aplan PD.

Leukemia. 2008 Apr;22(4):678-85. Epub 2007 Dec 20. Review.

3.

Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.

Huh JY, Chung S, Oh D, Kang MS, Eom HS, Cho EH, Han MH, Kong SY.

Korean J Lab Med. 2010 Apr;30(2):117-21. doi: 10.3343/kjlm.2010.30.2.117. Review.

5.

MLL leukemia and future treatment strategies.

Marschalek R.

Arch Pharm (Weinheim). 2015 Apr;348(4):221-8. doi: 10.1002/ardp.201400449. Epub 2015 Mar 4. Review.

PMID:
25740345
6.

Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.

Ayton PM, Cleary ML.

Oncogene. 2001 Sep 10;20(40):5695-707. Review.

7.

Transcription factor fusions in acute leukemia: variations on a theme.

Scandura JM, Boccuni P, Cammenga J, Nimer SD.

Oncogene. 2002 May 13;21(21):3422-44. Review.

Supplemental Content

Support Center